Seminars in Oncology
Volume 33 , Pages 15-18 , February 2006

Clinical Experience With Pemetrexed in Breast Cancer

  • Miguel Martin

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Miguel Martin, Servicio de Oncología Médica, Hospital Universitario San Carlos, Ciudad Universitaria s/n, 28040 Madrid, Spain

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr Martin has served as a consultant to Sanofi-Aventis, Bristol-Myers Squibb, Eli Lilly and Co, and Pharmamar.

PII: S0093-7754(05)00326-X

doi: 10.1053/j.seminoncol.2005.07.027

Seminars in Oncology
Volume 33 , Pages 15-18 , February 2006

Article Tools

* Image Usage & Resolution